Take the assessment
45-min intake with your dedicated health coach. A free health-score quiz is available before the paid intake.
Synthetic GHRH analog (first 29 amino acids of endogenous GHRH). Stimulates pulsatile GH release physiologically, preserving somatostatin feedback. Previously FDA-approved; withdrawn 2008 for manufacturing economics, not safety.
HSA/FSA eligible · No commitmentHSA/FSA eligible · No commitment
Sermorelin
Marketing purposes only. Actual medications, if prescribed, are dispensed by a licensed pharmacy.
How it works
45-min intake with your dedicated health coach. A free health-score quiz is available before the paid intake.
Complete lab panel ordered by your provider, drawn at any of 4,000 partnered lab locations nationwide. Results typically return within 14 days.
A licensed medical provider reviews your labs and history to evaluate whether Sermorelin is appropriate for you. Eligibility and any prescription are determined at the provider's discretion.
If your provider prescribes Sermorelin, it ships from a licensed pharmacy. Your coach supports you through follow-up labs and ongoing monitoring.
Every Marek client receives this baseline panel before a provider review. Your provider may add additional biomarkers based on your health history, symptoms, and goals, pulling from 1,000+ available markers. See more biomarkers →
Sex hormones
Adrenals & neurosteroids
Growth hormone / IGF-1
Thyroid hormones
Cardiovascular health
Insulin sensitivity
Liver & pancreas
Kidney function
Comprehensive Metabolic Panel (CMP)
Prostate health
Vitamins & minerals
Iron status
Complete Blood Count (CBC)
The science
Binds GHRH receptors on pituitary somatotrophs, stimulating endogenous GH synthesis and pulsatile release while preserving feedback inhibition from somatostatin and IGF-1.
Eligibility, dosing, and outcomes vary. Any prescription is at the discretion of a partnered licensed medical provider based on your labs and medical history.
Clinical evidence
BioDrugs (1998)
Improved growth velocity and IGF-1 normalization comparable to rhGH in GH-responsive children with preserved HPG axis regulation.
Safety profile
FAQ
Synthetic GHRH analog (first 29 amino acids of endogenous GHRH). Stimulates pulsatile GH release physiologically, preserving somatostatin feedback. Previously FDA-approved; withdrawn 2008 for manufacturing economics, not safety.
Treatments are dependent on licensed clinical prescription. Client costs vary based on individual labs and panel in treatments and services.